Pharmaceutical Technology

DECEMBER 29, 2022

Influenza vaccine stimulate the body's immune system to recognize the agent as foreign and destroy it. It also helps the body's immune system to 'remember' the agent, so that the immune system can easily recognize and destroy any of the microbes that it encounters again in the future. Fluarix is indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Immunization Vaccines Hospitals 40

Pharmaceutical Technology

DECEMBER 29, 2022

Influenza vaccine stimulate the body's immune system to recognize the agent as foreign and destroy it. It also helps the body's immune system to 'remember' the agent, so that the immune system can easily recognize and destroy any of the microbes that it encounters again in the future. Fluarix is indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Immunization Vaccines Hospitals 40

Druggist

SEPTEMBER 2, 2021

Additionally, this drug is also known as anti-parasite successful against all viruses like HIV, Dengue, Influenza , and Zika virus. And stated its judicial use in preventing corona infection. In the last year, this drug has emerged as a possible option for the treatment of covid.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Adverse Reactions Dosage Hospitals 52

Pharma Phorum

JANUARY 5, 2022

The next phase of the Covid-19 – from vaccines to treatments. New COVID-19 treatments will also be available in 2022, but they are not a panacea. Both companies have signed agreements to support access to these agents in low and middle-income countries.

HIV Treatment and Prevention Agents 80

HIV Treatment and Prevention Agents FDA Vaccines 80

Pharma Phorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face.

HIV Treatment and Prevention Agents 56

HIV Treatment and Prevention Agents Medication Delivery Vaccines Pharmaceutical Companies 56